Joshua Richter, Associate Professor of Medicine, Hematology, and Medical Oncology at The Tisch Cancer Institute, shared on X:
“Newly updated NCCN guidelines.
Now allows for prophylactic toci with Teclistamab.
Are you changing practice?”
Joshua Richter, Associate Professor of Medicine, Hematology, and Medical Oncology at The Tisch Cancer Institute, shared on X:
“Newly updated NCCN guidelines.
Now allows for prophylactic toci with Teclistamab.
Are you changing practice?”